MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41436-018-0036-2

Медицинская библиотека · Genetics in medicine : official journal of the American College of Medical Genetics · 2018

A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.

Horvat Claire, Johnson Renee, Lam Lien, Munro Jacob, Mazzarotto Francesco, Roberts Angharad M, Herman Daniel S, Parfenov Michael, Haghighi Alireza, McDonough Barbara, DePalma Steven R, Keogh Anne M, Macdonald Peter S, Hayward Christopher S, Roberts Amy, Barton Paul J R, Felkin Leanne E, Giannoulatou Eleni, Cook Stuart A, Seidman J G, Seidman Christine E, Fatkin Diane

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: We evaluated strategies for identifying disease-causing variants in genetic testing for dilated cardiomyopathy (DCM).

METHODS

Cardiomyopathy gene panel testing was performed in 532 DCM patients and 527 healthy control subjects. Rare variants in 41 genes were stratified using variant-level and gene-level characteristics.

RESULTS

A majority of DCM cases and controls carried rare protein-altering cardiomyopathy gene variants. Variant-level characteristics alone had limited discriminative value. Differentiation between groups was substantially improved by addition of gene-level information that incorporated ranking of genes based on literature evidence for disease association. The odds of DCM were increased to nearly 9-fold for truncating variants or high-impact missense variants in the subset of 14 genes that had the strongest biological links to DCM (P <0.0001). For some of these genes, DCM-associated variants appeared to be clustered in key protein functional domains. Multiple rare variants were present in many family probands, however, there was generally only one "driver" pathogenic variant that cosegregated with disease.

CONCLUSION

Rare variants in cardiomyopathy genes can be effectively stratified by combining variant-level and gene-level information. Prioritization of genes based on their a priori likelihood of disease causation is a key factor in identifying clinically actionable variants in cardiac genetic testing.

Для цитирования: Horvat Claire, Johnson Renee, Lam Lien, Munro Jacob, Mazzarotto Francesco, Roberts Angharad M, Herman Daniel S, Parfenov Michael, Haghighi Alireza, McDonough Barbara, DePalma Steven R, Keogh Anne M, Macdonald Peter S, Hayward Christopher S, Roberts Amy, Barton Paul J R, Felkin Leanne E, Giannoulatou Eleni, Cook Stuart A, Seidman J G, Seidman Christine E, Fatkin Diane. A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.. Genetics in medicine : official journal of the American College of Medical Genetics. 2018. DOI: 10.1038/s41436-018-0036-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.